Life Sciences & Pharmaceuticals
Informa provides a wide range of products and services for the life sciences, healthcare and pharmaceutical markets. From academics to professionals, from R&D to health economics, and from students to CEOs, Informa has the right event, book or periodical to suit your needs.
After decades of prosperity, pharmaceutical and biotech firms are reshaping R&D to drive growth, boost productivity and exploit new technology. A scientific and technological revolution is sweeping through the industry. The result will be better medicines and very different drug companies.
New genetic knowledge is resulting in greater quantities of drugs targeting more and more specific disease states. Progress in combinatorial chemistry and library technologies means designing 'small molecule' drugs is becoming easier. Progress in regulatory harmonisation and technological advance will mean cheaper, faster and more effective clinical trials. Alliances and joint ventures between biotech, contract research organisations and pharmaceutical companies are changing the face of the industry as we know it.
In such an environment of rapid change, Informa's conferences, books, journals, newsletters and information services provide senior level pharmaceutical executives with the information they need to manage and take advantage of these changes.
All of the following Informa businesses provide knowledge and skills in this area:
Adam Smith Conferences, Drug & Market Development, Garland Science, IBC Asia, IBC Life Sciences, IIR Australia, IIR Austria, IIR Brazil, IIR Czech Republic, IIR Exhibitions, IIR Germany, IIR Hungary, IIR Italy, IIR Middle East, IIR Netherlands, IIR Poland, IIR Spain, IIR Life Sciences, IIR USA, Informa Healthcare, PTi, and Taylor & Francis.
